Executive Summary
Publicis Groupe S.A. gains a stable $374M revenue stream through subsidiary Plowshare Group from a CDC National Tobacco Education Campaign contract ending March 30, 2026, with $275M already outlaid representing 74% of obligated value. This Time & Materials award under full competition underscores reliable U.S. government demand for advertising services.
Investors should monitor unexercised $124M options and post-2026 renewal potential amid funding and audit risks.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior General Federal Contracts digest from March 29, 2026.
Investment Signals (1)
- $374M CDC contract bolsters Publicis revenue (HIGH)▲
Plowshare Group, Publicis subsidiary, has $275M outlaid of $374M obligated under a multi-year Time & Materials deal, providing predictable cash flow through 2026.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
Time & Materials structure exposes to government audits on hours and rates.
- Market [HIGH RISK]▼
Only 74% ($275M) outlaid of $374M obligated; remaining $99M spend uncertain with 2026 end date.
Opportunities (2)
- ◆
$124M unexercised options could expand contract value to $498M.
- ◆
Potential follow-on contracts in CDC tobacco campaigns post-2026.
Sector Themes (1)
- ◆
Full-and-open competition award highlights ongoing federal priority on tobacco education via agencies.
Watch List (2)
- 👁
{"entity"=>"Publicis Groupe S.A.", "reason"=>"Single large contract concentrates 100% of period value; tracks parent financials.", "trigger"=>"Q1 2026 earnings for outlay updates or option news"}
- 👁
{"entity"=>"CDC Tobacco Campaign Funding", "reason"=>"Determines remaining $99M obligation and $124M options.", "trigger"=>"HHS budget releases or contract modifications"}
Get daily alerts with 1 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: General Federal Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals